Comparison of Ciclesonide (80 mcg or 160 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily in the Morning and Evening) in Pediatric Asthma Patients
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Ciclesonide (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Registrational; Therapeutic Use
- 04 May 2012 Takeda Global Research and Development Center added as company and lead trial centre as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History